— Know what they know.
Not Investment Advice

OPTN NASDAQ

OptiNose, Inc.
1W: +1.9% 1M: +4.7% 3M: +60.0% 1Y: -49.2% 3Y: -65.4% 5Y: -83.6%
$9.60
Last traded 2025-05-21 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $97.2M mcap · 6M float · 1.87% daily turnover · Short 18% of daily vol

📊 Key Metrics

TTM
$82M
Revenue
+10.6% YoY
$-30M
Net Income
+2.6% YoY
$-34M
Free Cash Flow
-5.6% YoY
90.5%
Gross Margin
-41.0%
Op. Margin
-121.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE37.2%
ROA-30.1%
ROIC176.3%

Valuation

P/E-4.5
P/B-2.4
EV/EBITDA556.1

Leverage

Debt/Equity-2.07
Current Ratio0.64
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z-8.90
Beneish M-1.73

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms